scispace - formally typeset
D

David Schellenberg

Researcher at University of London

Publications -  126
Citations -  10195

David Schellenberg is an academic researcher from University of London. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 49, co-authored 124 publications receiving 9496 citations. Previous affiliations of David Schellenberg include PATH & Ifakara Health Institute.

Papers
More filters
Journal ArticleDOI

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Selidji T Agnandji, +150 more
TL;DR: The RTS,S/AS01 vaccine provided protection against both clinical and severe malaria in African children, and serious adverse events occurred with a similar frequency in the two study groups.
Journal ArticleDOI

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Selidji T Agnandji, +168 more
TL;DR: The RTS,S/AS01 vaccine coadministered with EPI vaccines provided modest protection against both clinical and severe malaria in young infants.
Journal ArticleDOI

Inequities among the very poor: health care for children in rural southern Tanzania

TL;DR: Care-seeking behaviour is worse in poorer than in relatively rich families, even within a rural society that might easily be assumed to be uniformly poor.
Journal ArticleDOI

Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants

TL;DR: Iron supplementation of infants to prevent iron-deficiency anaemia, even in malaria-endemic areas is supported, and malaria chemoprophylaxis during the first year of life was effective in prevention of malaria and anaemia but apparently impaired the development of natural immunity.